Pas de connexion internet — affichage de la version enregistrée de la page.

bioAffinity Techn…

USUSD
← Vers le Screener

bioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
bioaffinitytech.com
Relations avec les Investisseurs
bioaffinitytech.com/contact/
Secteur
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Siège Social
SAN ANTONIO, United States
Direction
Maria Zannes
  • Maria Zannes · Chief Executive Officer, President and Director
  • Steven Girgenti · Executive Chairman
  • Roberto Rios · Director
  • Peter S. Knight · Director
  • Dallas J. Coleman · Vice President of Sales
Derniers Rapports
Trimestriel 2026 · 10-Q for the period ended 2026-03-31
Employés
57
Actions en Circulation
8.1 M au 2026-08-03
Flottant
532 257
Capitalisation Boursière
3.69 M USD
Initiés
0.82%
Investisseurs Institutionnels
5.62%
Secteur d'Activité (SIC)
Services-Commercial Physical & Biological Research
P/E
perte
P/B
5.04
FCF
−11.6 M USD
Dette
36.5 k USD
trésorerie nette
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
NAV
0.56 USD · P/NAV 5.09
Date du Bilan30.06.2026
Actifs7.62 M USD
− Passifs3.85 M USD
= NAV (capitaux propres des actionnaires de la société)3.77 M USD
− Écart d'Acquisition (Goodwill)1.40 M USD
− Actifs Incorporels688 k USD
= NAV Tangible1.68 M USD
Actions6 783 061
NAV par Action0.56 USD
VLV Tangible par Action0.25 USD
Prix de l'Action (BIAF)2.8300 USD
P/NAV5.09
Historique de la NAV
Date du BilanNAVNAV par Action
30.06.20263.77 M USD0.56 USD
31.03.20263.65 M USD0.81 USD
31.12.20257.28 M USD1.62 USD
30.09.20258.90 M USD2.57 USD
30.06.2025−2.14 M USD−0.08 USD
31.03.20251.44 M USD0.08 USD
31.12.20242.60 M USD5.01 USD
30.09.20243.12 M USD0.23 USD
Description

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksBIAFUSD2.83 +1.07%actions ordinaires

Cours sur 3 Mois

US:BIAF · USD
jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
ZANNES MARIA (Chief Exec…≈46.94%280 3592025-01-10
EDWARDS JAMES MICHAEL CP…≈20.11%120 1282025-01-10
ZANNES TIMOTHY PETER (Ge…≈9.17%54 7652025-01-10
REVELES XAVIER TRINIDAD…≈7.02%41 9432025-01-10
Sabby Management, LLC4.06%24 3772026-06-30
Blackrock Inc.1.1%6 5852026-06-30
Vanguard Capital Managem…0.62%3 7032026-06-30
VANGUARD INDEX FUNDS-Van…0.62%3 7032026-06-30
Geode Capital Management…0.57%3 3982026-06-30
J. Safra Sarasin Holding…0.47%2 8402026-06-30
Vanguard Fiduciary Trust…0.34%2 0712026-06-30
Susquehanna Internationa…0.3%1 7912026-06-30
Jane Street Group, LLC0.3%1 7862026-06-30
Fidelity Concord Street…0.28%1 6592026-07-31
State Street Corporation0.27%1 6062026-06-30
HRT Financial LP0.23%1 3892026-06-30
Fidelity Concord Street…0.08%5092026-07-31
Fidelity Concord Street…0.07%4342026-07-31
Fidelity Concord Street…0.03%1672026-07-31
GIRGENTI STEVEN (Officer…—1.09 M2025-01-10